Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Intec Pharma Ord Shr (NTEC)

0.420201   0.032 (8.16%) 08-07 14:54
Open: 0.39 Pre. Close: 0.3885
High: 0.4397 Low: 0.3852
Volume: 8,175,594 Market Cap: 30M
Intec Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. Its Accordion Pill is an oral drug delivery system that is designed to enhance the efficacy and safety of existing drugs and drugs in development by utilizing a gastric retention and specific release mechanism. The company's lead product candidate is Accordion Pill Carbidopa/Levodopa, which is in a Phase III clinical trial for the treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.41 - 0.413 0.413 - 0.415
Low: 0.374 - 0.377 0.377 - 0.379
Close: 0.386 - 0.39 0.39 - 0.394

Technical analysis

as of: 2020-08-07 2:28:56 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 0.69     One year: 0.92
Support: Support1: 0.26    Support2: 0.22
Resistance: Resistance1: 0.59    Resistance2: 0.79
Pivot: 0.44
Moving Average: MA(5): 0.41     MA(20): 0.41
MA(100): 0.29     MA(250): 0.45
MACD: MACD(12,26): 0.02     Signal(9): 0.03
Stochastic oscillator: %K(14,3): 16.78     %D(3): 21.30
RSI: RSI(14): 53.73
52-week: High: 1.56  Low: 0.13  Change(%): -4.6
Average Vol(K): 3-Month: 1108052  10-Days: 763965

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
NTEC has closed above bottom band by 35.6%. Bollinger Bands are 13.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 04 May 2020
Intec Pharma Announces $5.0 Million Registered Direct Offering - GlobeNewswire

Thu, 30 Jan 2020
Intec Pharma Announces Pricing of $6.5 Million Public Offering - GlobeNewswire

Wed, 31 Dec 1969

Wed, 31 Dec 1969

Wed, 31 Dec 1969

Wed, 31 Dec 1969

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 69
Shares Float (M) 56
% Held by Insiders 10.19
% Held by Institutions 17.02
Shares Short (K) 2,310
Shares Short P. Month (K) 1,060

Stock Financials

EPS -1.097
EPS Est This Year -1.670
EPS Est Next Year -1.250
Book Value (p.s.) 0.270
Profit Margin
Operating Margin
Return on Assets (ttm) -42.8
Return on Equity (ttm) -140.0
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.368
Qtrly Earnings Growth
Operating Cash Flow (M) -27
Levered Free Cash Flow (M) -19

Stock Valuations

PE Ratio -0.38
PEG Ratio
Price to Book value 1.53
Price to Sales
Price to Cash Flow -1.06

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.